Primary lateral sclerosis
A heterogeneous disorder composed of different subtypes?
Abstract
Objective: To determine identifiable subgroups of patients with primary lateral sclerosis (PLS) with distinct clinical features as a first step in identifying patients likely to have the same disorder.
Methods: Twenty-five patients meeting previously proposed diagnostic criteria for PLS were seen for examination, measurement of gait and finger tapping speed, and physiologic tests to assess motor pathways. Motor cortex excitability and central motor conduction time were assessed with transcranial magnetic stimulation. Brainstem motor pathways were assessed by the acoustic startle reflex. MRS was performed in a subgroup of patients to assess metabolites in the motor cortex.
Results: Fifty-six percent of the patients with PLS had a similar pattern of symptom progression, which the authors termed ascending. In these patients spasticity began in the legs and progressed slowly and steadily. Spasticity in the arms developed 3.6 years after the legs, on average, and speech impairment followed 1.5 years later. Motor evoked potentials were absent. MRS showed a mean reduction of N-acetylaspartate/creatinine in the motor cortex. The remaining patients with PLS had heterogeneous patterns of symptom progression and physiology.
Conclusions: Patients with PLS with an ascending progression of symptoms form a distinct clinical subgroup that may be amenable to investigations of etiology and treatment.
Get full access to this article
View all available purchase options and get full access to this article.
References
1.
Erb WH. Spastic and syphilitic spinal paralysis. Lancet . 1902; ii: 969–974.
2.
Fisher CM. Pure spastic paralysis of corticospinal origin. Can J Neurol Sci . 1977; 4: 251–258.
3.
Stark FM, Moersch FP. Primary lateral sclerosis. A distinct clinical entity. J Nerv Ment Dis . 1945; 102: 332–337.
4.
Gastaut JL, Michel B, Figarella-Branger D, Somma-Mauvais H. Chronic progressive spinobulbar spasticity. A rare form of primary lateral sclerosis. Arch Neurol . 1988; 45: 509–513.
5.
Beal MF, Richardson EP Jr . Primary lateral sclerosis: a case report. Arch Neurol . 1981; 38: 630–633.
6.
Pringle CE, Hudson AJ, Munoz DG, Kiernan JA, Brown WF, Ebers GC. Primary lateral sclerosis. Clinical features, neuropathology and diagnostic criteria. Brain . 1992; 115: 495–520.
7.
Younger DS, Chou S, Hays AP, et al. Primary lateral sclerosis. A clinical diagnosis reemerges. Arch Neurol . 1988; 45: 1304–1307.
8.
Swash M, Desai J, Misra VP. What is primary lateral sclerosis? J Neurol Sci . 1999; 170: 5–10.
9.
Rowland LP. Primary lateral sclerosis: disease, syndrome, both or neither? J Neurol Sci . 1999; 170: 1–4.
10.
Bruyn RP, Koelman JH, Troost D, de Jong JM. Motor neuron disease (amyotrophic lateral sclerosis) arising from longstanding primary lateral sclerosis. J Neurol Neurosurg Psychiatry . 1995; 58: 742–744.
11.
Kuipers-Upmeijer J, de Jager AE, Hew JM, Snoek JW, van Weerden TW. Primary lateral sclerosis: clinical, neurophysiological, and magnetic resonance findings. J Neurol Neurosurg Psychiatry . 2001; 71: 615–620.
12.
Le Forestier N, Maisonobe T, Piquard A, et al. Does primary lateral sclerosis exist? A study of 20 patients and a review of the literature. Brain . 2001; 124: 1989–1999.
13.
Le Forestier N, Maisonobe T, Spelle L, et al. Primary lateral sclerosis: further clarification. J Neurol Sci . 2001; 185: 95–100.
14.
Davis M, Gendelman DS, Tischler MD, Gendelman PM. A primary acoustic startle circuit: lesion and stimulation studies. J Neurosci . 1982; 2: 791–805.
15.
Yeomans JS, Frankland PW. The acoustic startle reflex: neurons and connections. Brain Res Brain Res Rev . 1996; 21: 301–314.
16.
Appel V, Stewart SS, Smith G, Appel SH. A rating scale for amyotrophic lateral sclerosis: description and preliminary experience. Ann Neurol . 1987; 22: 328–333.
17.
Mills KR, Nithi KA. Corticomotor threshold to magnetic stimulation: normal values and repeatability. Muscle Nerve . 1997; 20: 570–576.
18.
Samii A, Luciano CA, Dambrosia JM, Hallett M. Central motor conduction time: reproducibility and discomfort of different methods. Muscle Nerve . 1998; 21: 1445–1450.
19.
Matsumoto J, Fuhr P, Nigro M, Hallett M. Physiological abnormalities in hereditary hyperekplexia. Ann Neurol . 1992; 32: 41–50.
20.
Duyn JH, Gillen J, Sobering G, van Zijl PC, Moonen CT. Multisection proton MR spectroscopic imaging of the brain. Radiology . 1993; 188: 277–282.
21.
Yousry TA, Schmid UD, Alkadhi H, et al. Localization of the motor hand area to a knob on the precentral gyrus. A new landmark. Brain . 1997; 120: 141–157.
22.
Ziemann U, Tergau F, Wassermann EM, Wischer S, Hildebrandt J, Paulus W. Demonstration of facilitatory I wave interaction in the human motor cortex by paired transcranial magnetic stimulation. J Physiol . 1998; 511: 181–190.
23.
Rooney WD, Miller RG, Gelinas D, Schuff N, Maudsley AA, Weiner MW. Decreased N-acetylaspartate in motor cortex and corticospinal tract in ALS. Neurology . 1998; 50: 1800–1805.
24.
Wilkins DE, Hallett M, Weiss MM. Audiogenic startle reflex of man and its relationship to startle syndromes. Brain . 1986; 109: 561–573.
25.
Brown P, Rothwell JC, Thompson PD, Britton TC, Day BL, Marsden CD. The hyperekplexias and their relationship to the normal startle reflex. Brain . 1991; 114: 1903–1928.
26.
Fink JK. Progressive spastic paraparesis: hereditary spastic paraplegia and its relation to primary and amyotrophic lateral sclerosis. Semin Neurol . 2001; 21: 199–207.
27.
Mills KR, Nithi KA. Peripheral and central motor conduction in amyotrophic lateral sclerosis. J Neurol Sci . 1998; 159: 82–87.
28.
Triggs WJ, Menkes D, Onorato J, et al. Transcranial magnetic stimulation identifies upper motor neuron involvement in motor neuron disease. Neurology . 1999; 53: 605–611.
29.
Eisen A, Weber M. The motor cortex and amyotrophic lateral sclerosis. Muscle Nerve . 2001; 24: 564–573.
30.
Enterzari-Taher M, Eisen A, Stewart H, Nakajima M. Abnormalities of cortical inhibitory neurons in amyotrophic lateral sclerosis. Muscle Nerve . 1997; 20: 65–71.
31.
Brown WF, Ebers GC, Hudson AJ, Pringle CE, Veitch J. Motor-evoked responses in primary lateral sclerosis. Muscle Nerve . 1992; 15: 626–629.
32.
Sarchielli P, Pelliccioli GP, Tarducci R, et al. Magnetic resonance imaging and 1H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis. Neuroradiology . 2001; 43: 189–197.
33.
Smith CD. Serial MRI findings in a case of primary lateral sclerosis. Neurology . 2002; 58: 647–649.
34.
Pioro EP, Antel JP, Cashman NR, Arnold DL. Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo. Neurology . 1994; 44: 1933–1938.
35.
Chan S, Shungu DC, Douglas-Akinwande A, Lange DJ, Rowland LP. Motor neuron diseases: comparison of single-voxel proton MR spectroscopy of the motor cortex with MR imaging of the brain. Radiology . 1999; 212: 763–769.
36.
Block W, Karitzky J, Traber F, et al. Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease: subgroup analysis and follow-up measurements. Arch Neurol . 1998; 55: 931–936.
37.
Pohl C, Block W, Traber F, et al. Proton magnetic resonance spectroscopy and transcranial magnetic stimulation for the detection of upper motor neuron degeneration in ALS patients. J Neurol Sci . 2001; 190: 21–27.
38.
Suhy J, Miller RG, Rule R, et al. Early detection and longitudinal changes in amyotrophic lateral sclerosis by (1)H MRSI. Neurology . 2002; 58: 773–779.
39.
Bradley WG, Bowen BC, Pattany PM, Rotta F. H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis. J Neurol Sci . 1999; 169: 84–86.
40.
Bowen B. Amyotrophic lateral sclerosis. The search for a spectroscopic marker of upper motoneuron involvement. Arch Neurol . 2001; 58: 714–716.
41.
Rango M, Spagnoli D, Tomei G, Bamonti F, Scarlato G, Zetta L. Central nervous system trans-synaptic effects of acute axonal injury: a 1H magnetic resonance spectroscopy study. Magn Reson Med . 1995; 33: 595–600.
42.
Valls-Sole J, Sole A, Valldeoriola F, Munoz E, Gonzalez LE, Tolosa ES. Reaction time and acoustic startle in normal human subjects. Neurosci Lett . 1995; 195: 97–100.
43.
Siegmund GP, Inglis JT, Sanderson DJ. Startle response of human neck muscles sculpted by readiness to perform ballistic head movements. J Physiol . 2001; 535: 289–300.
44.
Valls-Sole J, Rothwell JC, Goulart F, Cossu G, Munoz E. Patterned ballistic movements triggered by a startle in healthy humans. J Physiol . 1999; 516: 931–938.
45.
Floeter MK, Sholomenko GN, Gossard JP, Burke RE. Disynaptic excitation from the medial longitudinal fasciculus to lumbosacral motoneurons: modulation by repetitive activation, descending pathways, and locomotion. Exp Brain Res . 1993; 92: 407–419.
46.
Gossard JP, Floeter MK, Degtyarenko AM, Simon ES, Burke RE. Disynaptic vestibulospinal and reticulospinal excitation in cat lumbosacral motoneurons: modulation during fictive locomotion. Exp Brain Res . 1996; 109: 277–288.
47.
Nieuwenhuijzen PH, Schillings AM, Van Galen GP, Duysens J. Modulation of the startle response during human gait. J Neurophysiol . 2000; 84: 65–74.
48.
Ishigaki S, Niwa J, Ando Y, et al. Differentially expressed genes in sporadic amyotrophic lateral sclerosis spinal cords–screening by molecular indexing and subsequent cDNA microarray analysis. FEBS Lett . 2002; 531: 354–358.
49.
Becker AJ, Wiestler OD, Blumcke I. Functional genomics in experimental and human temporal lobe epilepsy: powerful new tools to identify molecular disease mechanisms of hippocampal damage. Prog Brain Res . 2002; 135: 161–173.
Information & Authors
Information
Published In
Copyright
© 2003.
Publication History
Received: July 3, 2002
Accepted: January 17, 2003
Published online: April 22, 2003
Published in print: April 22, 2003
Authors
Metrics & Citations
Metrics
Citation information is sourced from Crossref Cited-by service.
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Primary Lateral Sclerosis: An Overview, Journal of Clinical Medicine, 13, 2, (578), (2024).https://doi.org/10.3390/jcm13020578
- Primary lateral sclerosis, Motor System Disorders, Part II: Spinal Cord, Neurodegenerative, and Cerebral Disorders and Treatment, (89-99), (2023).https://doi.org/10.1016/B978-0-323-98817-9.00021-1
- Neurometabolic Alterations in Motor Neuron Disease: Insights from Magnetic Resonance Spectroscopy, Journal of Integrative Neuroscience, 21, 3, (2022).https://doi.org/10.31083/j.jin2103087
- Mills’ syndrome is a unique entity of upper motor neuron disease with N-shaped progression: Three case reports, World Journal of Clinical Cases, 10, 19, (6664-6671), (2022).https://doi.org/10.12998/wjcc.v10.i19.6664
- Primary Lateral Sclerosis: Clinical, radiological and molecular features, Revue Neurologique, 178, 3, (196-205), (2022).https://doi.org/10.1016/j.neurol.2021.04.008
- The Upper Motor Neuron—Improved Knowledge from ALS and Related Clinical Disorders, Brain Sciences, 11, 8, (958), (2021).https://doi.org/10.3390/brainsci11080958
- Upper Motor Neuron Disorders: Primary Lateral Sclerosis, Upper Motor Neuron Dominant Amyotrophic Lateral Sclerosis, and Hereditary Spastic Paraplegia, Brain Sciences, 11, 5, (611), (2021).https://doi.org/10.3390/brainsci11050611
- Frontotemporal Pathology in Motor Neuron Disease Phenotypes: Insights From Neuroimaging, Frontiers in Neurology, 12, (2021).https://doi.org/10.3389/fneur.2021.723450
- Measuring disease progression in primary lateral sclerosis, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 21, sup1, (59-66), (2021).https://doi.org/10.1080/21678421.2020.1837179
- The clinical spectrum of primary lateral sclerosis, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 21, sup1, (3-10), (2021).https://doi.org/10.1080/21678421.2020.1837178
- See more
Loading...
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.